- Shopping Bag ( 0 items )
From The CriticsReviewer: Ali Morshedi, MD (Ochsner Clinic Foundation)
Description: This book reviews the role of hypercholesterolemia in atherosclerosis and the effect of therapy in decreasing the outcome events. This book of 182 pages reviews clinical trials in the last decade in a simplified manner.
Purpose: The goal is to bridge the evidence from clinical trials to implementation of these findings in everyday clinical practice. It accomplishes its goal by enhancing our basic understanding and implementation of this information at the bedside by guiding selection of patients, laboratory tests, and appropriate therapy.
Audience: The principal audience is general practitioners rather than specialists. The editor moves from the basic aspect of hyperlipidemia to more clinically relevant subjects. Readers with different medical backgrounds can enjoy this concise overview. Contributors are extensively published authorities in this field. The editor, Doctor Jonathan Abrams, professor of medicine at the University of New Mexico Health Sciences Center, is a recognized authority in this field.
Features: The 11 chapters review the basic science and pathophysiology of hypercholesterolemia, present the evidence from multiple large-scale prospective clinical trials in a very useful and easy to understand format, and incorporate these findings into important clinical recommendations. Figures and tables summarize the information and enhance the reader's understanding.
Assessment: This short overview is an excellent source of information for clinicians interested in understanding and treating hypercholesterolemia. As part of our armamentarium to fight the epidemic of atherosclerosis, this book plays an important role in encouraging the transfer of evidence from clinical trials to clinical practice.